can DoctorBrad or OVF provide their view on the results..... I.e. excellent, great , good or fine...
How is this compare to the phase 2a? coz I am a bit concerned on the line that no significant difference in overall patient cohort
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-5
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
0.045(10.2%) |
Mkt cap ! $266.8M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 49.0¢ | 44.0¢ | $2.019M | 4.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 15954 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |